Harrow
Melissa Kang has extensive work experience in various sales and account management roles. Melissa'smost recent position is as an Area Sales Director at Harrow, where they focus on Retina and Surgical products in the Western region. Prior to that, they worked as a Director of Strategic Accounts at Harrow. Melissa also has experience as a Strategic Accounts Manager at EyePoint Pharmaceuticals, a Key Account Manager at Ocular Therapeutix, Inc., and an Executive Medical Sales Consultant at Novartis. Melissa's earlier career includes roles as a Senior Glaucoma Sales Consultant at Alcon, a Medical Sales Representative at GlaxoSmithKline, and a Sales Account Manager at Newell Brands. Additionally, they had a teaching experience at IDEAL English Academy, which allowed their to gain valuable cross-cultural and adaptability skills.
Melissa Kang holds a Bachelor of Arts (BA) degree in Communication and Media Studies from UC San Diego. Melissa also has a TESOL Teaching Certification from LanguageCorps.
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.